The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 2007, 179, 21 -25
Copyright © 2007 by The American Association of Immunologists, Inc.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorén, F. B.
Right arrow Articles by Hellstrand, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorén, F. B.
Right arrow Articles by Hellstrand, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
Hazardous Substances DB
*OXYGEN

Cutting Edge: Antioxidative Properties of Myeloid Dendritic Cells: Protection of T Cells and NK Cells from Oxygen Radical-Induced Inactivation and Apoptosis1

Fredrik B. Thorén, Åsa Betten, Ana I. Romero and Kristoffer Hellstrand2

Department of Infectious Medicine, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 Disclosures
 References
 
Dendritic cells (DCs) communicate with nonadaptive and adaptive lymphocytes on multiple levels. Efficient DC-lymphocyte interactions require that lymphocytes remain viable and functional also under conditions of oxidative stress, such as in microbial infection or in the malignant microenvironment. For this study, we exposed human T and NK cells to oxidants delivered either by autologous phagocytes or in the form of exogenous hydrogen peroxide. In accordance with earlier studies, these lymphocytes became dysfunctional and subsequently apoptotic. The presence of myeloid DCs efficiently rescued T cells (CD4+ and CD8+) and NK cells from oxidant-induced inactivation and apoptosis. The mechanism of the myeloid DC-mediated lymphocyte protection was, at least in part, explained by the capacity of the myeloid DCs to neutralize extracellular oxygen radicals, which, in turn, was reversible upon coincubation with a catalase inhibitor. Our results are suggestive of a novel aspect of DC-lymphocyte interaction that may have implications for lymphocyte function in inflamed tissue.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 Disclosures
 References
 
Dendritic cells (DCs)3 form a pivotal part of adaptive immunity by virtue of their uniquely efficient presentation of Ag to T cells (1). However, DCs also communicate with NK cells (2, 3, 4), which are innate effector cells that are important in the early phase of infection (5, 6). The reciprocal interaction between DCs and NK cells has been identified as a putative link between innate and adaptive immunity. For example, DCs are stimulated by pathogen-derived components, which results in the production of NK cell-activating cytokines (7, 8). In parallel, interactions between NK cells and target cells can activate NK cells to secrete cytokines leading to DC activation (9, 10, 11), and NK cell-mediated lysis of foreign cells provides DCs with Ags (12). In addition, NK cells have been shown to selectively eliminate DCs that fail to differentiate into mature APCs (3, 9).

In infected tissue, viral and bacterial components activate the NADPH oxidase of neutrophils and mononuclear phagocytes (MPs), resulting in the production of large amounts of reactive oxygen species ("oxygen radicals") (13). These toxic compounds are important for killing phagocytosed microorganisms or infected cells and have been implicated in DC activation (14, 15). However, the release of radicals may be detrimental to surrounding cells and tissues ("oxidative stress"), including immune cells. We and others have previously reported that phagocyte-derived radicals compromise NK and T cell function and induce programmed cell death in these cells (16, 17, 18, 19, 20, 21). Myeloid DCs (mDCs) are equipped with a functional NADPH oxidase (22, 23) and might thus share the ability of other myeloid cells to inactivate human NK cells and T cells. In this study, we investigated whether human mDCs affected the function and viability of lymphocytes under conditions of oxidative stress in vitro. Our results are suggestive of a novel aspect of DC-lymphocyte interaction that may have implications for lymphocyte function in inflamed tissue.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 Disclosures
 References
 
Cells

Peripheral venous blood was obtained as freshly prepared leukopacks from healthy blood donors at the Blood Center, Sahlgren’s University Hospital, Göteborg, Sweden. The blood (65 ml/donor) was mixed with 92.5 ml of Iscove’s modified DMEM, 35 ml of 6% dextran, and 7.5 ml of acid citrate dextrose. After incubation for 15 min at room temperature, the supernatant was carefully layered on top of a Ficoll-Hypaque (Lymphoprep; Nycomed) density gradient. After centrifugation at 380 x g for 15 min, mononuclear cells were collected at the interface. The mononuclear cells were further separated into lymphocytes and MPs using a countercurrent centrifugal elutriation technique as described elsewhere (18). In brief, cells were fed into an ultracentrifuge at 2100 rpm, where the sedimentation rate of cells is balanced by a counter-directed flow through the chamber. By slowly increasing the flow rate, fractions of cells of well-defined sizes were collected. From this separation procedure, a fraction with >90% MPs was recovered. Lymphocyte fractions enriched for NK cells and T cells contained <3% phagocytes. These lymphocyte fractions were pooled and subjected to further separation. Purified preparations of NK cells were obtained from elutriated lymphocytes using the BD IMag NK cell isolation kit (BD Biosciences) according to the instructions provided by the manufacturer.

Differentiation of mDCs

MPs were differentiated to DCs using a 7-day standard protocol with GM-CSF and IL-4 (24). After 7 days, the majority of cells were immature CD14–CD11c+CD83– DCs as assessed by flow cytometry. Seven-day cultures of MPs (CD14+CD11c+, henceforth referred to as adherent MPs (adMP)) in the absence of cytokines were used as controls. In some experiments, pure preparations of CD14–CD11c+CD83– DCs were sorted out using a BD FACSAria cytometer equipped with three laser lines (405, 488, and 633 nm) and FACSDiva version 5 software (BD Biosciences). In other experiments, mDCs were maturated by the addition of IL-1beta (4 ng/ml), IL-6 (100 U/ml), PGE2 (0.5 µg/ml), and TNF-{alpha} (10 U/ml) to the DC cultures on day 5.

Lymphocyte cell death

One hundred thousand lymphocytes were incubated in a total volume of 200 µl with or without 50,000 mDCs or adMPs in the presence of oxidants, either derived from freshly isolated MPs (50,000 or 100,000 per well) or as exogenously added hydrogen peroxide (H2O2). After overnight incubation, lymphocytes were assayed for end-stage, oxidant-induced cell death by using flow cytometry based on the altered characteristics displayed by end-stage apoptotic cells, i.e., a reduced forward scatter and an increased right angle scatter (16). Apoptosis was confirmed using annexin V staining as described elsewhere (18). In some experiments, lymphocytes were exposed to MPs that were stimulated with the formylated bacterial peptide fMLF (0.1 µM) or yeast cells (MP/yeast ratio of 1:4).

Cytotoxicity

NK cell cytotoxicity was assayed using PKH-26-labeled K562 cells as described elsewhere (18). Labeled cells were incubated for 4 h with NK cells at an E:T ratio of 2.5:1. Before flow cytometry analysis, 0.5 µM TO-PRO-3 (TP3) was added. Lysed target cells were identified as double-positive PKH-26+TP3+ cells. NK cytotoxicity was also assayed using a traditional 51Cr-release assay as described elsewhere (25).

Staining for cell surface thiols

The relative number of cell surface thiols on cells was determined using Alexa Fluor 633-coupled maleimide (ALM-633; Invitrogen Life Technologies) (26, 27). In brief, cells were incubated with 5 µM ALM-633 for 15 min on ice. After extensive washing, cells were stained with Abs directed against CD3, CD8, CD56, and CD16. Data were acquired and analyzed using a BD FACSCanto II with FACSDiva version 5 software, and results are presented as the median fluorescence intensity (MFI) values of ALM-633 staining.

H2O2 consumption assay

DCs or adherent mononuclear cells were resuspended in Krebs-Ringer glucose buffer (200,000 cells/ml) and incubated with 30 µM H2O2 for 15 min. The remaining H2O2 was determined fluorometrically by measuring the oxidation of p-hydroxyphenyl acetic acid (PHPA) (0.5 mg/ml) catalyzed by HRP (4 U/ml) using a PerkinElmer fluorescence spectrophotometer (LC50) (excitation at 320 nm; emission at 400 nm) (28).

Abs and reagents

The following antihuman mAbs were purchased from BD Biosciences: anti-CD3 (PerCP and allophycocyanin), anti-CD8 (AmCyan, PerCP, and allophycocyanin), anti-CD11c (PE-Cy5 and allophycocyanin), anti-CD14 (FITC), anti-CD16 (FITC and allophycocyanin-Cy7), anti-CD56 (PE, PE-Cy7, and allophycocyanin), anti-CD83 (PE). BD CompBeads and FITC- and PE-conjugated annexin V were from BD Biosciences. The following compounds were used: PHPA, PJ34, and PKH-26 (Sigma-Aldrich); dextran (Kabi Pharmacia); acid citrate dextrose (Baxter); BSA (ICN Biomedicals); EDTA and hydrogen peroxide (VWR International); Ficoll-Hypaque, Lymphoprep (Nycomed); TP3 and ALM-633 (Invitrogen Life Technologies); and HRP (Boehringer-Mannheim).

Statistics

Paired samples t tests were used throughout the study. MFI values were transformed logarithmically before statistical calculation. All reported p values are two-sided.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
Disclosures
 References
 
Oxygen radicals, which are synthesized by the NADPH oxidase-dependent reduction of oxygen, are toxic to a variety of cells and tissues. Within the population of lymphocytes, NK cells appear to be unusually sensitive to radical-induced toxicity. NK cells exposed to oxygen radicals, either delivered by adjacent phagocytes or in the form of exogenous H2O2, are thus rapidly inactivated and highly prone to apoptosis (16, 18). Although the mechanisms of radical-induced toxicity in NK cells have only been partially explored, it seems clear that the inactivation and ensuing apoptosis are critically dependent on the integrity of the poly(ADP-ribose) polymerase-1/apoptosis-inducing factor axis, with a minor contribution by traditional pathways of apoptosis such as the caspase cascade (18). T cells, in particular CD8+ cells, are sensitive to oxygen radical-inflicted toxicity by similar intracellular pathways of apoptosis induction (18).

Several myeloid cell types have been shown to inactivate NK cells and T cells by this mechanism. Thus, freshly recovered MPs and neutrophils as well as malignant granulocytic cells from subjects with chronic myeloid leukemia all efficiently trigger dysfunction and apoptosis in lymphocytes by synthesizing and releasing oxygen radicals (16, 29, 30). mDCs are of myeloid origin, and we therefore chose to explore whether these cells share the apoptosis-inducing properties of other myeloid cells. In these experiments, enriched MPs were differentiated to DCs by using a standard protocol with GM-CSF and IL-4. After 7 days, immature DCs with the CD14–CD11c+CD83– phenotype were recovered from the culture and incubated with enriched NK or T cells overnight. Neither the mDCs nor the population of adherent mononuclear cells significantly affected lymphocyte viability in these experiments (not shown). These data imply the following: 1) that mDCs do not induce apoptosis in lymphocytes; and 2) that MPs lose their capacity to trigger apoptosis in lymphocytes after adherence; the latter finding is in agreement with a previous report (31).

In the next series of experiments we assessed the function and viability of NK and T cells under conditions of oxidative stress that were inflicted either by the addition of freshly recovered MPs or by exogenous H2O2. In agreement with earlier studies, a large proportion of lymphocytes acquired apoptotic features and became dysfunctional when exposed to MPs as well as after treatment with H2O2 (16, 18). The presence of mDCs, however, efficiently rescued NK and T cells from inactivation and apoptosis (Figs. 1 and 2). Thus, NK cells remained viable and functional in the presence of radical-producing phagocytes or H2O2 when coincubated with mDCs, and a similar mDC-mediated protection was observed for CD8+ and CD4+ T cells (Fig. 1). No apparent difference was observed between the protection exerted by immature mDCs and that by mature mDCs (data not shown). The capacity to rescue lymphocytes was significantly lower for adherent MPs, i.e., MPs cultured for the same period of time in the absence of GM-CSF and IL-4, than for corresponding mDCs (Fig. 1). To ensure that mDCs rather than contaminating cells in the GM-CSF/IL-4-stimulated cell preparations mediated the protection, mDCs were sorted using a FACS on the basis of CD11c+CD14– phenotype and added to NK/T cell preparations. The sorted mDCs were as efficient as the crude preparation of mDCs in conveying NK and T cell protection against oxidant stress. Notably, mDCs were almost completely resistant to H2O2 used at concentrations sufficient to induce significant apoptosis in lymphocytes (60–250 µM; data not shown).


Figure 1
View larger version (15K):
[in this window]
[in a new window]

  		FIGURE 1. mDCs protect human lymphocytes from oxidant-induced cell death. A and B, Human lymphocytes (Ly) were incubated overnight with freshly isolated autologous MPs or H2O2 in the presence or absence of DCs or corresponding adMPs (mDC/lymphocyte and adMP/lymphocyte ratios at 1:2). Lymphocytes were significantly protected by mDCs against phagocytes (ratio 0.5, p < 0.001; ratio of 1, p < 0.05) (A) and H2O2 (125 µM, p < 0.05; 250 µM, p < 0.001) (B), but not by the adherent MPs. C and D, Oxidant-exposed lymphocytes were stained for lymphocyte surface Ags, and the percentages of apoptotic NK cells (with CD3–CD56dim phenotype) and CD8+/CD4+ T cells were determined. All lymphocyte subsets were significantly protected by mDCs (CD56dim, p = 0.0002 and p < 0.0001; CD8+, p = 0.003 and p = 0.004; CD4+, p = 0.0003 and p = 0.003 for MPs and H2O2, respectively; n = 6). E, Activation of MPs by addition of the bacterial peptide fMLF or by triggering phagocytosis of yeast cells enhanced the production of oxidants (data not shown) and the ensuing lymphocyte cell death (fMLF, p = 0.004; yeast, p = 0.016; n = 5). The addition of mDCs significantly protected lymphocytes from oxygen radicals released from fMLF- or yeast-activated MPs (fMLF, p = 0.008; yeast, p = 0.001,; n = 5). Ctrl, Control; Unstim., unstimulated.

 

Figure 2
View larger version (25K):
[in this window]
[in a new window]

  		FIGURE 2. Maintenance of NK cell cytotoxic function by mDCs during oxidative stress. A, Upper right dot plot, NK cells are negative for the membrane dye PKH-26 and are displayed as purple dots. The orange PKH-26+ K562 target cells form two populations; the one to the right is lysed and thus stained by TP3 whereas intact cells are TP3 negative and found to the left. In the histograms, PKH-26+ K562 cells were assayed for TP3 staining. Numbers are the percentage of lysed target cells in a representative experiment. NK cell cytotoxic function was maintained by mDCs despite oxidative challenge by MPs (MP/NK ratio of 0.5, p = 0.02; n = 4) or H2O2 (60 µM, p < 0.05; n = 4). B, Similar results were obtained in a chromium-release microcytotoxicity assay. Lymphocytes (Ly) were incubated with or without MPs at designated ratios, and NK cell-mediated cytotoxicity against 51Cr-labeled K562 cells was assessed. mDCs preserved the cytotoxic function of NK cells in the presence of oxygen radical-producing phagocytes (p < 0.001 for both MP/Ly ratios; n = 7). Ctrl, Control.

 
To shed light on the mechanisms of mDC-mediated lymphocyte protection, we first investigated whether supernatants from 7-day cultures of mDC could reconstitute the protective properties of these cells. mDC-derived supernatants, however, did not rescue lymphocytes from oxygen radical-induced toxicity (data not shown). Next, we investigated the capacity of mDCs to neutralize exogenous oxygen radicals. mDCs or 7-day cultures of adherent MPs were incubated with 30 µM H2O2 for 15 min and the remaining H2O2 was determined by measuring PHPA oxidation. As shown in Fig. 3A, mDCs were significantly more efficient at degrading H2O2 than the adherent MPs.


Figure 3
View larger version (17K):
[in this window]
[in a new window]

  		FIGURE 3. Consumption of hydrogen peroxide by mDCs. mDCs or corresponding adherent MPs were incubated with 30 µM H2O2 for 15 min. The remaining H2O2 was determined by measuring PHPA oxidation. A, mDCs neutralized significantly more H2O2 than adherent MPs (p = 0.002, n = 5). B, The mean ± SEM of four experiments in which the catalase inhibitor 3-AT (30 mM) reversed the mDC-mediated protection of lymphocytes against H2O2 (p = 0.02). C, 30 mM 3-AT blocked the capacity of mDCs to neutralize H2O2 (p = 0.007; n = 4). Ctrl, Control.

 
Catalase is an essential antioxidative enzyme that degrades H2O2 and is expressed by several types of myeloid cells (32). A catalase inhibitor, 3-amino-1,2,4-triazole (3-AT), was used in experiments aimed at clarifying whether the catalase expressed by mDCs contributed to the antioxidative properties of these cells. The presence of 3-AT significantly reversed the mDC-induced protection of lymphocytes against H2O2-induced apoptosis (Fig. 3B). In addition, 3-AT significantly reduced the capacity of mDCs to consume exogenous H2O2 (Fig. 3C).

Cells use thiols such as glutathione and thioredoxin for protection against the detrimental effects of oxidants. To assess the surface thiol expression by mDCs and adherent MPs, we stained these cells for thiols using fluorochrome-conjugated maleimide. As shown in Fig. 4, the thiol expression was significantly higher in mDCs than in the adherent MPs. In addition, lymphocytes incubated with mDCs, but not with adherent MPs, rapidly up-regulated the levels of surface thiols, thus suggesting that mDCs may convey resistance to oxidants by elevating thiol expression in lymphocytes (Fig. 4B).


Figure 4
View larger version (14K):
[in this window]
[in a new window]

  		FIGURE 4. mDCs express high levels of surface thiols and induce thiol up-regulation on lymphocytes. A, mDCs displayed higher binding of the thiol-reactive reagent ALM-633 than adherent MPs (p = 0.019; n = 5). B, Experiments in which lymphocytes were incubated in the presence or absence of mDCs before ALM-633 staining. mDCs approximately doubled the expression of cell surface thiols on NK cells and CD8+ and CD4+ T cells after overnight incubation (CD56dim NK cells, p = 0.0008; CD8+, p = 0.028; CD4+, p = 0.012; n = 5). The effect was evident already after 1 h of lymphocyte-mDC incubation (CD56dim NK cells, p = 0.036; CD8+, p = 0.003; CD4+, p = 0.007; n = 5; not shown). Ctrl, Control.

 
It was recently shown that DCs release thioredoxin upon interaction with Ag-specific T cells, a process that is inhibited by glutamate (33). To investigate whether thioredoxin release contributed to the protection of lymphocytes, we added glutamate, at concentrations reportedly sufficient to inhibit thioredoxin release, to the mDC-lymphocyte cocultures and subsequently exposed them to oxidants. The addition of glutamate did not affect the ability of mDCs to protect lymphocytes from oxidants in these experiments (not shown), thus suggesting that thioredoxin release was not the principal mechanism of mDC-induced protection against oxidants.

We conclude that human mDCs are endowed with an efficient antioxidative defense system that conveys protection of NK and T cells from oxidant-induced inactivation. mDCs thus may have the capacity to uphold lymphocyte viability and function under conditions of oxidative stress such as in acute and chronic infections or in the malignant microenvironment. Our data suggest that a significant part of the protection against oxidants exerted by mDCs is related to catalase activity in these cells. In addition, our data reveal that mDCs convey protection against oxidants by increasing thiol expression in lymphocytes by an as yet undefined mechanism. It should be pointed out, however, that recent proteomic-based analyses have revealed that several antioxidative proteins are up-regulated as MPs differentiate into mDCs (34), and multiple mechanisms are therefore likely to contribute to the observed mDC-mediated lymphocyte protection.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This study was supported by the Swedish Cancer Society, the Swedish Research Council, the Inga-Britt and Arne Lundberg Research Foundation, and the Sahlgrenska Academy at Göteborg University. Back

2 Address correspondence and reprint requests to Dr. Kristoffer Hellstrand, Department of Infectious Medicine, Göteborg University, Guldhedsgatan 10b, S-413 46 Göteborg, Sweden. E-mail address: kristoffer.hellstrand{at}microbio.gu.se Back

3 Abbreviations used in this paper: DC, dendritic cell; adMP, adherent mononuclear phagocyte; ALM-633, Alexa Fluor 633-coupled maleimide; 3-AT, 3-amino-1,2,4-triazole; mDC, myeloid dendritic cell; MFI, median fluorescence intensity; MP, mononuclear phagocyte; PHPA, p-hydroxyphenyl acetic acid; TP3, TO-PRO-3. Back

Received for publication February 23, 2007. Accepted for publication May 1, 2007.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 Disclosures
 References
 

  1. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667. [Medline]
  2. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-411. [Medline]
  3. Carbone, E., G. Terrazzano, G. Ruggiero, D. Zanzi, A. Ottaiano, C. Manzo, K. Karre, S. Zappacosta. 1999. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29: 4022-4029. [Medline]
  4. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351. [Abstract/Free Full Text]
  5. Biron, C. A., K. S. Byron, J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735. [Medline]
  6. Cerwenka, A., L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49. [Medline]
  7. Borg, C., A. Jalil, D. Laderach, K. Maruyama, H. Wakasugi, S. Charrier, B. Ryffel, A. Cambi, C. Figdor, W. Vainchenker, et al 2004. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275. [Abstract/Free Full Text]
  8. Gerosa, F., A. Gobbi, P. Zorzi, S. Burg, F. Briere, G. Carra, G. Trinchieri. 2005. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174: 727-734. [Abstract/Free Full Text]
  9. Piccioli, D., S. Sbrana, E. Melandri, N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335-341. [Abstract/Free Full Text]
  10. Mailliard, R. B., Y. I. Son, R. Redlinger, P. T. Coates, A. Giermasz, P. A. Morel, W. J. Storkus, P. Kalinski. 2003. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J. Immunol. 171: 2366-2373. [Abstract/Free Full Text]
  11. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, L. Moretta, A. Moretta. 2005. NK-dependent DC maturation is mediated by TNF{alpha} and IFN-{gamma} released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571. [Abstract/Free Full Text]
  12. Iyoda, T., S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, R. M. Steinman, K. Inaba. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302. [Abstract/Free Full Text]
  13. Klebanoff, S. J.. 1980. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med. 93: 480-489. [Abstract/Free Full Text]
  14. Rutault, K., C. Alderman, B. M. Chain, D. R. Katz. 1999. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radical Biol. Med. 26: 232-238. [Medline]
  15. Verhasselt, V., M. Goldman, F. Willems. 1998. Oxidative stress up-regulates IL-8 and TNF-{alpha} synthesis by human dendritic cells. Eur. J. Immunol. 28: 3886-3890. [Medline]
  16. Hansson, M., A. Asea, U. Ersson, S. Hermodsson, K. Hellstrand. 1996. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J. Immunol. 156: 42-47. [Abstract]
  17. Hansson, M., S. Hermodsson, M. Brune, U. H. Mellqvist, P. Naredi, A. Betten, K. R. Gehlsen, K. Hellstrand. 1999. Histamine protects T cells and natural killer cells against oxidative stress. J. Interferon Cytokine Res. 19: 1135-1144. [Medline]
  18. Thoren, F. B., A. I. Romero, K. Hellstrand. 2006. Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes. J. Immunol. 176: 7301-7307. [Abstract/Free Full Text]
  19. Dobmeyer, T. S., S. Findhammer, J. M. Dobmeyer, S. A. Klein, B. Raffel, D. Hoelzer, E. B. Helm, D. Kabelitz, R. Rossol. 1997. Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radical Biol. Med. 22: 775-785. [Medline]
  20. Kono, K., F. Salazar-Onfray, M. Petersson, J. Hansson, G. Masucci, K. Wasserman, T. Nakazawa, P. Anderson, R. Kiessling. 1996. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 26: 1308-1313. [Medline]
  21. Schmielau, J., O. J. Finn. 2001. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61: 4756-4760. [Abstract/Free Full Text]
  22. Savina, A., C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I. C. Moura, A. M. Lennon-Dumenil, M. C. Seabra, G. Raposo, S. Amigorena. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218. [Medline]
  23. Elsen, S., J. Doussiere, C. L. Villiers, M. Faure, R. Berthier, A. Papaioannou, N. Grandvaux, P. N. Marche, P. V. Vignais. 2004. Cryptic O2- -generating NADPH oxidase in dendritic cells. J. Cell Sci. 117: 2215-2226. [Abstract/Free Full Text]
  24. Chapuis, F., M. Rosenzwajg, M. Yagello, M. Ekman, P. Biberfeld, J. C. Gluckman. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27: 431-441. [Medline]
  25. Thoren, F., A. Romero, M. Lindh, C. Dahlgren, K. Hellstrand. 2004. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J. Leukocyte Biol. 76: 1180-1186. [Abstract/Free Full Text]
  26. Sahaf, B., K. Heydari, L. A. Herzenberg, L. A. Herzenberg. 2003. Lymphocyte surface thiol levels. Proc. Natl. Acad. Sci. USA 100: 4001-4005. [Abstract/Free Full Text]
  27. Gelderman, K. A., M. Hultqvist, J. Holmberg, P. Olofsson, R. Holmdahl. 2006. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. USA 103: 12831-12836. [Abstract/Free Full Text]
  28. Dahlgren, C., A. Karlsson. 1999. Respiratory burst in human neutrophils. J. Immunol. Methods 232: 3-14. [Medline]
  29. Mellqvist, U. H., M. Hansson, M. Brune, C. Dahlgren, S. Hermodsson, K. Hellstrand. 2000. Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 96: 1961-1968. [Abstract/Free Full Text]
  30. Bellner, L., F. Thoren, E. Nygren, J.-A. Liljeqvist, A. Karlsson, K. Eriksson. 2005. A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J. Immunol. 174: 2235-2241. [Abstract/Free Full Text]
  31. Hellstrand, K., S. Hermodsson. 1990. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2. Int. Arch. Allergy Appl. Immunol. 92: 379-389. [Medline]
  32. Klebanoff, S. J.. 1999. Oxygen metabolites from phagocytes. J. Gallin, and R. Snyderman, eds. Inflammation: Basic Principles and Clinical Correlates 3rd ed.721-768. Lippincott Williams & Wilkins, Philadelphia.
  33. Angelini, G., S. Gardella, M. Ardy, M. R. Ciriolo, G. Filomeni, G. Di Trapani, F. Clarke, R. Sitia, A. Rubartelli. 2002. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99: 1491-1496. [Abstract/Free Full Text]
  34. Rivollier, A., L. Perrin-Cocon, S. Luche, H. Diemer, J. M. Strub, D. Hanau, A. van Dorsselaer, V. Lotteau, C. Rabourdin-Combe, T. Rabilloud, C. Servet-Delprat. 2006. High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis. Mol. Cell. Proteomics 5: 726-736. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
C. Richter, M. H. S. Juan, J. Will, R. P. Brandes, U. Kalinke, S. Akira, J. M. Pfeilschifter, M. Hultqvist, R. Holmdahl, and H. H. Radeke
Ncf1 Provides a Reactive Oxygen Species-Independent Negative Feedback Regulation of TLR9-Induced IL-12p70 in Murine Dendritic Cells
J. Immunol., April 1, 2009; 182(7): 4183 - 4191.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D.-M. Kuang, Q. Zhao, J. Xu, J.-P. Yun, C. Wu, and L. Zheng
Tumor-Educated Tolerogenic Dendritic Cells Induce CD3{epsilon} Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways
J. Immunol., September 1, 2008; 181(5): 3089 - 3098.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorén, F. B.
Right arrow Articles by Hellstrand, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorén, F. B.
Right arrow Articles by Hellstrand, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
Hazardous Substances DB
*OXYGEN

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS